Home Cart 0 Sign in  
X

[ CAS No. 261767-10-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 261767-10-6
Chemical Structure| 261767-10-6
Chemical Structure| 261767-10-6
Structure of 261767-10-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 261767-10-6 ]

Related Doc. of [ 261767-10-6 ]

Alternatived Products of [ 261767-10-6 ]

Product Details of [ 261767-10-6 ]

CAS No. :261767-10-6 MDL No. :MFCD12090273
Formula : C11H12O4 Boiling Point : -
Linear Structure Formula :- InChI Key :BAWCYPPHRYLPKS-UHFFFAOYSA-N
M.W : 208.21 Pubchem ID :18382450
Synonyms :

Calculated chemistry of [ 261767-10-6 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.36
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 53.4
TPSA : 44.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.58
Log Po/w (XLOGP3) : 1.86
Log Po/w (WLOGP) : 1.63
Log Po/w (MLOGP) : 1.26
Log Po/w (SILICOS-IT) : 2.31
Consensus Log Po/w : 1.93

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.4
Solubility : 0.828 mg/ml ; 0.00397 mol/l
Class : Soluble
Log S (Ali) : -2.42
Solubility : 0.789 mg/ml ; 0.00379 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.92
Solubility : 0.252 mg/ml ; 0.00121 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.51

Safety of [ 261767-10-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 261767-10-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 261767-10-6 ]
  • Downstream synthetic route of [ 261767-10-6 ]

[ 261767-10-6 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 261767-10-6 ]
  • [ 274910-19-9 ]
YieldReaction ConditionsOperation in experiment
88% With sodium hydroxide In diethyl ether; water Example 5
5-hydroxymethyl-1,4-benzodioxan (5).
To a suspension of lithium aluminum hydride (7.0 g, 0.18 mmol) in dry diethyl ether (100 mL) was added a solution of ethyl 1,4-benzodioxan-5-carboxylate (35 g, 0.17 mmol) in diethyl ether (100 mL).
After boiling under reflux for 2 h, the reaction mixture was cooled to 0° C. and carefully treated with water (35 mL) and 4N aqueous sodium hydroxide (35 mL).
The resulting mixture was filtered and dried (Na2SO4).
Evaporation of the solvents afforded 25 g (88percent) crystalline title compound: mp 51-53° C.; 1H NMR (CDCl3) δ 2.50 (s, 1H), 4.20-4.3 (m, 4H), 4.60 (s, 2H), 6.75-6.90 (m, 3H).
Reference: [1] Patent: US2002/32205, 2002, A1,
  • 2
  • [ 3943-73-5 ]
  • [ 1643-19-2 ]
  • [ 107-06-2 ]
  • [ 261767-10-6 ]
YieldReaction ConditionsOperation in experiment
94% With hydrogenchloride; sodium chloride; potassium carbonate In water A mixture of ethyl 2,3-dihydroxybenzoate (1000 g), tetra-n-butyl-ammonium bromide (880 g), potassium carbonate (1552 g), 1,2-dichloroethane (3216 g), and water (10 kg) was refluxed for 5 hours.
The solution was cooled and extracted with toluene.
The extract was washed with a solution of 1N hydrochloric acid and sodium chloride.
The solution was partially concentrated and filtered through silica gel (300 g).
The filtrated was concentrated to give the title compound (1074 g, 94percent); m.p. 48-51° C.
Reference: [1] Patent: US6172062, 2001, B2,
  • 3
  • [ 4442-53-9 ]
  • [ 64-17-5 ]
  • [ 261767-10-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2014, vol. 62, # 11, p. 1110 - 1118
[2] Patent: CN103664910, 2017, B, . Location in patent: Paragraph 011
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 261767-10-6 ]

Esters

Chemical Structure| 877997-98-3

[ 877997-98-3 ]

Phenyl 2-hydroxy-4,5-dimethoxybenzoate

Similarity: 0.96

Chemical Structure| 88709-17-5

[ 88709-17-5 ]

Ethyl 2-ethoxy-4-methylbenzoate

Similarity: 0.96

Chemical Structure| 2150-42-7

[ 2150-42-7 ]

Methyl 2,3-dimethoxybenzoate

Similarity: 0.94

Chemical Structure| 177429-27-5

[ 177429-27-5 ]

Ethyl 4-(benzyloxy)-3-hydroxybenzoate

Similarity: 0.92

Chemical Structure| 3943-73-5

[ 3943-73-5 ]

Ethyl 2,3-dihydroxybenzoate

Similarity: 0.92

Related Parent Nucleus of
[ 261767-10-6 ]

Benzodioxans

Chemical Structure| 4442-53-9

[ 4442-53-9 ]

2,3-Dihydrobenzo[b][1,4]dioxine-5-carboxylic acid

Similarity: 0.94

Chemical Structure| 4442-54-0

[ 4442-54-0 ]

2,3-Dihydro-1,4-benzodioxine-6-carboxylic acid

Similarity: 0.87

Chemical Structure| 823225-66-7

[ 823225-66-7 ]

Methyl 8-bromo-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate

Similarity: 0.81

Chemical Structure| 29668-44-8

[ 29668-44-8 ]

2,3-Dihydrobenzo[b][1,4]dioxine-6-carbaldehyde

Similarity: 0.75

Chemical Structure| 2879-20-1

[ 2879-20-1 ]

1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone

Similarity: 0.70